Patent · US Active

Derivatives of 6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-carboxylic acid amides

US8575360B2 · kind B2 · utility

0Cited by

29References

34Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Rene Lemieux · Boston, US
Steven Richard Brunette · Ridgefield, US
Joshua Courtney Horan · Somerville, US
Jennifer A. Kowalski · New Milford, US
Michael David Lawlor · Seymour, US
Bryan McKibben · White Plains, US
Craig Andrew Miller · Penfield, US
Antonio J. Barbosa · Ave Maria, US

Key dates

Filing date	May 26, 2010
Grant date	Nov 5, 2013
Priority date	—
Expiry date	May 26, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D519/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Derivatives of 6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-carboxylic acid amide exhibit good inhibitory effect upon the interaction of CAMs and Leukointegrins and are thus useful in the treatment of inflammatory disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.